Adimab

Business Data, Corporate Office and Headquarter Address

About

Adimab is Drug Discovery in United States that focus on therapeutic human antibodies business. Founded in 2007. They cover business area such as developer, yeast-base therapeutic human antibody, maturation, production, yeast-base immunoglobulin, healthcare professional, cancer, autoimmune and infectious disease.

Business Type

Drug Discovery

Country

United States

Founded

2007
( 17 years old in 2024 )

Company Focus

Therapeutic Human Antibodies

Website

-

Corporate Office and Headquarter Office address:

7 Lucent Drive
Lebanon, NH 03766
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

developeryeast-base therapeutic human antibodymaturationproductionyeast-base immunoglobulinhealthcare professionalcancerautoimmune and infectious disease

* We use standard office opening hours in near Adimab's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Adimab Frequently Asked Questions

What or who is Adimab?

Adimab is Drug Discovery business from United States that founded in 2007 (17 years old in 2024), Adimab business is focusing on Therapeutic Human Antibodies.

Where is Adimab headquarter and corporate office address?

Adimab headquarter office and corporate office address is located in 7 Lucent Drive Lebanon, NH 03766 United States.

Where is Adimab country origins?

Adimab was founded in United States.

What is Therapeutic Human Antibodies business focus on?

In 2024, Adimab is currently focus on therapeutic human antibodies sector.

Therapeutic Human Antibodies Business Interest from Google Trend

Above is snippet of Google Trends for "therapeutic human antibodies" term, if you have problem loading the snippet, please visit here: Google Trend.

Disclaimer: This website is not affiliated with Adimab, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.